Literature DB >> 16108858

Heel ulcers don't heal in diabetes. Or do they?

S Y Chipchase1, K A Treece, N Pound, F L Game, W J Jeffcoate.   

Abstract

AIM: To obtain information on outcome of heel ulcers in diabetes.
METHODS: Data were recorded prospectively on all patients with heel ulcers who were referred to a specialist multidisciplinary clinic between 1 January 2000 and 30 November 2003. Outcomes were assessed on 31 March 2004.
RESULTS: There were 157 heel ulcers in the patients referred in the period. Three ulcers were excluded from analysis because of associated osteomyelitis. Of 154 remaining ulcers (121 limbs; 97 patients, 55 male; mean age 68.5 +/- 12.8 sd years), 101 (65.6%) healed after a median (range) 200 (24-1225) days. Of 53 non-healed ulcers, 11 (7.1% of 154) were resolved by major amputation, 30 (19.5% of 154) were unhealed at time of patient's death, and 12 (7.8% of 154) remained unhealed. Ulcers healed in 59 of 97 affected patients (60.8%). Twenty-six patients (26.8% of 97) died during the period, of whom 20 died with ulcers unhealed. Worse outcomes were observed in larger ulcers (P = 0.001, Mann-Whitney U-test = 1883.5) and limbs with clinical evidence of peripheral arterial disease (P = 0.001, Mann-Whitney U-test = 1163.00). Backward step-wise logistic regression analysis showed 70.1% of healing could be predicted from these two baseline characteristics.
CONCLUSIONS: The common perception that 'heel ulcers don't heal' is not reflected in clinical practice. Outcome is generally favourable even in a population often affected by serious comorbidity and with limited life expectancy. These data can be used to help define management plans, as well as a basis for counselling of the individual patient.

Entities:  

Mesh:

Year:  2005        PMID: 16108858     DOI: 10.1111/j.1464-5491.2005.01665.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Heel ulcers do heal in patients with diabetes.

Authors:  Hedvig Örneholm; Jan Apelqvist; Jan Larsson; Magnus Eneroth
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

Review 2.  A review of the surgical management of heel pressure ulcers in the 21st century.

Authors:  David C Bosanquet; Ann M Wright; Richard D White; Ian M Williams
Journal:  Int Wound J       Date:  2015-02-16       Impact factor: 3.315

Review 3.  Slow to heel: a literature review on the management of diabetic calcaneal ulceration.

Authors:  Rachel Khoo; Shirley Jansen
Journal:  Int Wound J       Date:  2018-02-12       Impact factor: 3.315

4.  Heel Wounds Predict Mortality but Not Amputation after Infrapopliteal Revascularization.

Authors:  Abhisekh Mohapatra; Jon C Henry; Efthimios D Avgerinos; Rabih A Chaer; Steven A Leers; Aureline Boitet; Michael J Singh; Eric S Hager
Journal:  Ann Vasc Surg       Date:  2018-03-06       Impact factor: 1.466

5.  Risk Factors for Major Amputation on Hindfoot Ulcers in Hospitalized Diabetic Patients.

Authors:  Kyung-Chul Moon; Ki-Bum Kim; Seung-Kyu Han; Seong-Ho Jeong; Eun-Sang Dhong
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-05-03       Impact factor: 4.730

6.  Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.

Authors:  Isis B Yera-Alos; Liuba Alonso-Carbonell; Carmen M Valenzuela-Silva; Angela D Tuero-Iglesias; Martha Moreira-Martínez; Ivonne Marrero-Rodríguez; Ernesto López-Mola; Pedro A López-Saura
Journal:  BMC Pharmacol Toxicol       Date:  2013-09-03       Impact factor: 2.483

7.  Evaluation of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: study protocol for a randomised controlled trial.

Authors:  William Jeffcoate; Frances Game; Patricia Price; Ceri Phillips; Vivienne Turtle-Savage
Journal:  Trials       Date:  2014-11-26       Impact factor: 2.279

8.  Fluid management and strength postsimulated use of primary and secondary dressings for treating diabetic foot ulcers: Robotic phantom studies.

Authors:  Adi Lustig; Amit Gefen
Journal:  Int Wound J       Date:  2021-06-16       Impact factor: 3.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.